That's great, 10 doctors is pretty huge considering how...

That's great, 10 doctors is pretty huge considering how much they each spend on average per year. There was another one recently in Europe that had around 50 doctors (I believe), although the doctors were rotated between different MIGS procedures so it wasn't solely iTrack Advance. I'm glad to see them targeting the global market more. It's still very much in its infancy but I would like to see the global market become a majority of EYE's sales. The insurers in the US have proved they care more about money than the patients, and so having greater diversification of revenue would be great to ensure we never have to worry about them again (not that I think we do - but diversification is still always helpful). China is potentially a massive market in the making for EYE, especially when iTrack Advance is approved there (which should be very soon)